Philogen SpA (MIL:PHIL) Accumulated Depreciation: €-23.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:PHIL Philogen SpA MIL:PHIL
50 GF Score
Price €23.35
GF Value €234.37
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Philogen SpA Accumulated Depreciation?

Philogen SpA MIL:PHIL -0.85% 50 Accumulated Depreciation is €-23.0 Mil as of Dec. 2025. GuruFocus rates MIL:PHIL with a GF Score™ of 50/100 and a GF Value™ of €234.37 (Possible Value Trap). The stock has 3 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Philogen SpA's quarterly accumulated depreciation increased from Dec. 2024 (€-19.2 Mil) to Jun. 2025 (€-21.1 Mil) and increased from Jun. 2025 (€-21.1 Mil) to Dec. 2025 (€-23.0 Mil).

Philogen SpA's annual accumulated depreciation increased from Dec. 2023 (€-15.7 Mil) to Dec. 2024 (€-19.2 Mil) and increased from Dec. 2024 (€-19.2 Mil) to Dec. 2025 (€-23.0 Mil).

Philogen SpA Accumulated Depreciation Related Terms

Philogen SpA Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Philogen SpA's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Philogen SpA Accumulated Depreciation Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial -9.62 -2.92 -15.73 -19.25 -23.03

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.73 -17.28 -19.25 -21.15 -23.03
MIL:PHIL
50GF Score
Philogen SpA MIL:PHIL
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Philogen SpA Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of €-23.0 Mil mean?
Philogen SpA (MIL:PHIL) has a Accumulated Depreciation of €-23.0 Mil as of Dec. 2025. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Philogen SpA and its competitors.
Is Philogen SpA's Accumulated Depreciation too high?
Philogen SpA's current Accumulated Depreciation is €-23.0 Mil. Overall, Philogen SpA has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Philogen SpA's Accumulated Depreciation compare to VRTX and REGN?
Philogen SpA's Accumulated Depreciation of €-23.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Biotechnology company?
A good Accumulated Depreciation depends on the Biotechnology industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Philogen SpA and its competitors. Philogen SpA's current Accumulated Depreciation is €-23.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Philogen SpA stock overvalued right now?
Based on GuruFocus' analysis, Philogen SpA (MIL:PHIL) is currently considered Possible Value Trap. The stock's GF Value™ is €234.37, compared to a current price of €23.35 — trading 90% below its estimated fair value. The current Accumulated Depreciation is €-23.0 Mil. Philogen SpA's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Philogen SpA (MIL:PHIL), the current Accumulated Depreciation is €-23.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Philogen SpA (MIL:PHIL) Overvalued in 2026?

Based on GuruFocus' analysis, Philogen SpA stock appears to be undervalued. The current stock price of €23.35 is trading 90% below its estimated GF Value™ of €234.37. GuruFocus considers Philogen SpA to be Possible Value Trap.

Key valuation signals for MIL:PHIL:

  • Accumulated Depreciation: €-23.0 Mil
  • GF Value™: €234.37 vs. price of €23.35 (90% below fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the MIL:PHIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Philogen SpA Business Description

Other Exchanges 78Q:Germany
Address Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company engaged in the research and development of antibody-based therapeutics for the treatment of cancer and chronic inflammatory diseases. The company's pipeline includes products such as Nidlegy, Fibromun, Darleukin, and Dekavil, targeting oncology and other serious conditions. Geographically, the company operates in the European Union, Switzerland, and the United States of America.
50GF Score

Get the complete analysis for MIL:PHIL

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.35
Price
€234.37
GF Value